Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01970254 · ClinicalTrials.gov registry record

Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy

A clinical trial, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
2,206
Enrollment target

NCT01970254: Completed study, sponsored by M.D. Anderson Cancer Center.

NCT01970254 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,206 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01970254 has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
2,206 participants
Enrollment target

Study Summary

This trial studies hepatitis B screening strategies of new cancer patients scheduled to undergo chemotherapy. Patients with cancer and hepatitis B virus infection are at risk of reactivation of infection after chemotherapy. Hepatitis B virus infection reactivation can be prevented by starting antivirals before chemotherapy in patients who are hepatitis B virus infection positive. Hepatitis B screening may help doctors prevent the reactivation of hepatitis B virus infection after chemotherapy.

Primary Outcome

Number of screened participants (new cancer patients undergoing chemotherapy) with positive hepatitis B virus (HBV) infection compared to total screened. Prospective, universal screening of eligible MD Anderson cancer patients not known to have HBV infection using three HBV screening tests (HBsAg, anti-HBc, and anti-HBs) prior to chemotherapy.

Interventions

  • OTHER Survey Administration
  • OTHER Hepatitis B Screening

Trial Details

FieldValue
Enrollment Target 2,206 participants
Start Date 2013-06-24
Est. Completion 2022-07-19
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT01970254 record still lists

NCT01970254 is an observational study that tracks outcomes without assigning an intervention. Its 2,206 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 2 interventions - of which Survey Administration is the first listed.

NCT01970254 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01970254 about?

NCT01970254 is a clinical study titled "Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy". This trial studies hepatitis B screening strategies of new cancer patients scheduled to undergo chemotherapy. Patients with cancer and hepatitis B virus infection are at risk of reactivation of infection after chemotherapy. Hepatitis B virus infection reactivation can be prevented by starting antivi...

What is the current status of trial NCT01970254?

This trial is currently completed. The enrollment target is 2,206 participants. The study started on 2013-06-24. Estimated completion is 2022-07-19.

What interventions are being tested in trial NCT01970254?

The interventions under investigation include: Survey Administration (OTHER), Hepatitis B Screening (OTHER).

Who is sponsoring clinical trial NCT01970254?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05654207 · 2,200 participants · NA

    WeCare: A System of Care for Black Youth

  • NCT06144554 · 2,200 participants

    Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

  • NCT06526988 · 2,200 participants · NA

    Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

  • NCT06682650 · 2,200 participants · NA

    Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01970254, the US trial registry maintained by the National Library of Medicine. NCT01970254 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.